MADELINE CORSON-O'DONNELL: Open Payments
NPI 1710450317 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 15 payments from 9 companies in 2025. Trend: 2023 $206 · 2024 $337 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $72 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Novo Nordisk Inc | 2 | $45 |
| Exact Sciences Corporation | 2 | $44 |
| ABBVIE INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: NURTEC ODT, VRAYLAR, BEXSERO, SHINGRIX, PREVNAR 20, JARDIANCE, Wegovy, GARDASIL 9.
Industry payments across PA — which companies pay providers there.
